Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 5
Results: 14
Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 434, doi. 10.1002/cpdd.942
- By:
- Publication type:
- Article
Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 453, doi. 10.1002/cpdd.938
- By:
- Publication type:
- Article
Relationship of the Calcitonin Gene‐Related Peptide Monoclonal Antibody Galcanezumab Pharmacokinetics and Capsaicin‐Induced Dermal Blood Flow in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 440, doi. 10.1002/cpdd.929
- By:
- Publication type:
- Article
Hemodialysis Clearance of Enarodustat (JTZ‐951), an Oral Erythropoiesis Stimulating Agent, in Patients with End‐Stage Renal Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 463, doi. 10.1002/cpdd.923
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, Three‐Way Crossover Study in Healthy Participants to Investigate the Effect of Savolitinib on the QTc Interval.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 521, doi. 10.1002/cpdd.896
- By:
- Publication type:
- Article
Pharmacokinetics, Bioequivalence, and Safety Studies of Pantoprazole Sodium Enteric‐Coated Tablets in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 502, doi. 10.1002/cpdd.888
- By:
- Publication type:
- Article
Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 510, doi. 10.1002/cpdd.884
- By:
- Publication type:
- Article
A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 556, doi. 10.1002/cpdd.883
- By:
- Publication type:
- Article
Thorough QT/QTc Study Evaluating the Effect of Macimorelin on Cardiac Safety Parameters in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 494, doi. 10.1002/cpdd.872
- By:
- Publication type:
- Article
Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 542, doi. 10.1002/cpdd.871
- By:
- Publication type:
- Article
First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 471, doi. 10.1002/cpdd.869
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of 2 Immediate‐Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 535, doi. 10.1002/cpdd.864
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 486, doi. 10.1002/cpdd.851
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 429, doi. 10.1002/cpdd.712
- Publication type:
- Article